首页> 外文OA文献 >Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors

【2h】

Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors

机译：单独的TLR9激动剂左撇子瘤微环境对肿瘤微环境的有益调节和产生抗肿瘤反应，并与检查点抑制剂组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kerstin Kapp; Barbara Volz; Detlef Oswald; Burghardt Wittig; Matthias Baumann; Manuel Schmidt;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors [J] . Kerstin Kapp, Barbara Volz, Detlef Oswald, Oncoimmunology. . 2019,第12期

机译：单独的TLR9激动剂左撇子瘤微环境对肿瘤微环境的有益调节和抗肿瘤反应的产生及与检查点抑制剂的组合
2. Immunotherapy for Prostate Cancer: Where Do We Go From Here? PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular Therapies [J] . Patel Amar, Fong Lawrence Oncology . 2018,第6期

机译：前列腺癌的免疫疗法：我们从这里去哪里？第2部分：检查点抑制剂，免疫疗法组合，肿瘤微环境调制和细胞疗法
3. Immunotherapy for Prostate Cancer: Where Do We Go From Here? PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular Therapies [J] . Patel Amar, Fong Lawrence Oncology . 2018,第6期

机译：前列腺癌的免疫疗法：我们从这里去哪里？第2部分：检查点抑制剂，免疫疗法组合，肿瘤微环境调制和细胞疗法
4. Combination of angiogenesis inhibitors increases the anti-tumor efficacy of photodynamic therapy in a human bladder tumor xenograft model [C] . Ramaswamy Bhuvaneswari, Yik Yuen Gan, Patricia SP Thong, World congress of the International Photodynamic Association . 2009

机译：血管生成抑制剂的组合增加了光动力疗法在人膀胱肿瘤异种移植模型中的抗肿瘤功效
5. Understanding How Adrenergic Stress Signaling Impacts the Anti-Tumor Immune Response and the Efficacy of Checkpoint Inhibitors in Murine Tumor Models [D] . Bucsek, Mark Joseph. 2019

机译：了解肾上腺素能应激信号如何影响抗肿瘤免疫应答以及检查点抑制剂在鼠肿瘤模型中的疗效
6. Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors [O] . Kerstin Kapp, Barbara Volz, Detlef Oswald, 2019

机译：单独和与检查点抑制剂联合使用的TLR9激动剂来菲莫特对肿瘤微环境的有益调节和抗肿瘤反应的产生
7. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy [O] . Daqing Wang, Wayne Jiang, Fugang Zhu, 2018

机译：IMO-2125的肿瘤微环境调制肿瘤微环境，新型TLR9激动剂，用于癌症免疫疗法

Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅